BCR and cancer: A gene set enrichment analysis on these differentially targeted genes reveals that they are involved in the transcriptional misregulation of cancer and various immune-related Reactome pathways that include “Creation of C4 and C2 activators,” “Initial triggering of complement,” and “Signaling by the B Cell Receptor (BCR)” (Supplementary Tables S1 and S2).